Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 21Recruiting 8Unknown 6Terminated 4Withdrawn 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Breast Neoplasms 369Neoplasms 253Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 192Lung Neoplasms 140Colorectal Neoplasms 137Neoplasm Metastasis 132Pancreatic Neoplasms 131Leukemia, Myeloid, Acute 126Multiple Myeloma 122Lymphoma 114Carcinoma, Hepatocellular 111Ovarian Neoplasms 98Melanoma 97Recurrence 93Leukemia 88Head and Neck Neoplasms 88Leukemia, Lymphocytic, Chronic, B-Cell 86Brain Neoplasms 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Glioblastoma 77Lymphoma, Non-Hodgkin 73Squamous Cell Carcinoma of Head and Neck 71Lymphoma, Follicular 70Lymphoma, Large B-Cell, Diffuse 66Colonic Neoplasms 66Carcinoma, Renal Cell 61Hematologic Neoplasms 59Sarcoma 55Glioma 53

Interventions

Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Metabolic Syndrome × Clear all
NCT03708913 2020-11-02

Neuromodulation for Hypothalamic Obesity

University of British Columbia

Phase NA Withdrawn
CNS

Craniopharyngioma, Metabolic Syndrome, Sexual Infantilism

NCT03173807 2017-10-06

ProNEST

University of Pittsburgh

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡